The DOI matches its Crossref record.
Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial
Abstract
Summary: Background Previous studies suggest that sublingual immunotherapy (SLIT) represents a safer alternative to injection immunotherapy but equivalent efficacy is yet to be confirmed. Objective To evaluate the efficacy and safety of SLIT in grass pollen‐induced seasonal rhinoconjunctivitis. Methods A randomized, placebo‐controlled trial in 56 adults over 18 months. Outcome measures included diary scores of seasonal symptoms and medication use, overall assessments, conjunctival and intradermal provocation tests and serum antibody measurements. To investigate possible mechanisms, sublingual biopsies were taken for measurement of local T cells, antigen‐presenting cells and IL‐12 mRNA expression. Results There were no significant differences between the immunotherapy (IT) and placebo groups for diary symptom scores (P = 0.48) or rescue medication (P = 0.19). The patients' overall assessment of hayfever severity compared with previous years showed a highly significant improvement in favour of the IT group (P < 0.02). After treatment the late skin response was smaller (P = 0.003) and the ratio of serum allergen‐specific IgG4/IgE was higher (P = 0.05) in the IT group. Both of these variables correlated with the clinical response to SLIT. There were no differences between groups in either the sublingual epithelium or lamina propria for numbers of CD3+ cells (epithelium: P = 0.9, lamina propria: P = 0.2), CD1a+ cells (P = 0.3, P = 0.25), CD68+ cells (P = 0.9, P = 1.0) or IL‐12 mRNA+ cells (P = 0.6, P = 0.4). Local side‐effects were minor and there were no serious treatment‐related adverse events. Conclusion Grass pollen sublingual immunotherapy was well tolerated. Although there was no significant change in diary scores, the improvement in overall assessments, which correlated with inhibition of the late skin response and increases in serum IgG4 : IgE ratio, indicates the need for larger, dose‐ranging studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Allergic Rhinitis and Its Impact on Asthma
Bousquet, J., van Cauwenberge, P., & Khaltaev, N. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118891 · Cited by 3,588
Immunological mechanisms of allergen-specific immunotherapy
Larché, M., Akdis, C. A., & Valenta, R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1934 · Cited by 849
Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis*
Wilson, D. R., Torres Lima, M., & Durham, S. R. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00699.x · Cited by 660
Self-citationNovembre, E., Galli, E., Landi, F., Caffarelli, C., Pifferi, M., De Marco, E., Burastero, S. E., Calori, G., Benetti, L., Bonazza, P., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.07.012 · Cited by 499
Dahl, R., Kapp, A., Colombo, G., de Monchy, J. G. R., Rak, S., Emminger, W., Rivas, M. F., Ribel, M., & Durham, S. R. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.05.003 · Cited by 436
Self-citation
Metadata
- Authors
- Lima, M. T., Wilson, D., Pitkin, L., Roberts, A., Nouri‐Aria, K., Jacobson, M., Walker, S., & Durham, S.
- Venue
- Clinical & Experimental Allergy
- Publisher
- Wiley
- Published
- 2002-04
- Volume
- 32
- Issue
- 4
- Pages
- 507-514
- ISSN
- 0954-7894 (ISSN-L)
- 1365-2222
- OpenAlex
- W2042555734
- Cited by
- 188
- References
- 0
- FWCI
- 5.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. https://app.cochat.ai/papers/10.1046/j.0954-7894.2002.01327.x
- The paper
- Lima, M. T., Wilson, D., Pitkin, L., Roberts, A., Nouri‐Aria, K., Jacobson, M., Walker, S., & Durham, S. (2002). Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clinical & Experimental Allergy. https://doi.org/10.1046/j.0954-7894.2002.01327.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.